Direct Reprogramming of Hematopoietic Progenitor Cells into Neural Stem Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 3:05 min • July 8th, 2025
Begin with a cell suspension of genetically altered hematopoietic progenitor cells.
These cells express transcription factors required for their reprogramming into neural stem cells. This process is called direct reprogramming.
Transfer the cells to an extracellular matrix-coated multiwell plate with a neural progenitor medium, and incubate.
The extracellular matrix provides a three-dimensional scaffold for cell attachment and growth.
During incubation, transcription factors expressed by the hematopoietic progenitor cell initiate a sequence of molecular events that allow its transformation into a neural stem cell.
The neural progenitor medium contains factors that favor the survival of induced neural stem cells.
After incubation, replace this medium with a fresh neural progenitor medium to promote cell multiplication.
Detach the cells using a cell scraper.
Collect this suspension and transfer the cells to a well containing neural stem cell medium.
Incubate for maintenance of induced neural stem cells.
When the cells are 30 to 50% confluent, aspirate the supernatant and reserve, and then add 1 milliliter of neural progenitor medium to each well. To make a backup plate using the spheres in the supernatant, centrifuge the reserve supernatant at 170 times g for 10 minutes.
Then, aspirate the supernatant and resuspend the pellet in neural progenitor medium. Plate in a matrigel-coated 24-well plate; change the medium in each plate of cells every other day until the cells reach 60% to 80% confluence, usually after one week.
Once the cells reach the required confluence, aspirate the supernatant, and add 1 milliliter of neural stem cell medium to each well. Then, dissociate the cells by using a cell scraper followed by very gentle pipetting.
Next, transfer the cells from one well of the 24-well plate into one well of a 6-well plate. Add another milliliter of medium to the well, and after repeating the procedure for all wells, place the 6-well plate into the 37 degrees Celsius 5% carbon dioxide incubator.
Change the full volume of medium every other day until the cells reach 60% confluence. After each time, dissociate and replate the cells at a 1-to-3 ratio as just shown.
Overview
This article describes a method for direct reprogramming of genetically altered hematopoietic progenitor cells into neural stem cells. The process involves using a neural progenitor medium and an extracellular matrix to facilitate cell growth and transformation.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Stem Cell Research
Background
- Hematopoietic progenitor cells can be genetically modified to express specific transcription factors.
- Direct reprogramming allows for the conversion of these cells into neural stem cells.
- The use of an extracellular matrix supports cell attachment and growth.
- Neural progenitor medium is essential for the survival and maintenance of induced cells.
Purpose of Study
- To establish a reliable method for generating neural stem cells from hematopoietic progenitor cells.
- To explore the potential of direct reprogramming in regenerative medicine.
- To optimize conditions for cell growth and maintenance during the reprogramming process.
Methods Used
- Cell suspension of genetically altered hematopoietic progenitor cells.
- Incubation in a neural progenitor medium on an extracellular matrix.
- Medium changes to promote cell multiplication and maintenance.
- Cell detachment and replating at specific confluence levels.
Main Results
- Successful transformation of hematopoietic progenitor cells into neural stem cells.
- Optimal conditions for cell growth and maintenance were established.
- Cells reached the desired confluence for further experimentation.
- Backup plates were created to ensure cell viability and availability.
Conclusions
- The method provides a viable approach for generating neural stem cells.
- Direct reprogramming holds promise for applications in neuroscience and regenerative therapies.
- Further studies are needed to explore the functional capabilities of the induced neural stem cells.
Frequently Asked Questions
Executive Industry Relevance
Direct reprogramming of hematopoietic progenitor cells into neural stem cells offers a streamlined approach to generate disease-relevant neural models from accessible peripheral blood sources. This method reduces reliance on pluripotent intermediates, enhancing predictive confidence in target validation and mechanistic de-risking for neurodegenerative disease research. It supports early discovery workflows by providing a scalable, reproducible system for assay development and lead identification.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses using patient-derived neural stem cells without pluripotent reprogramming.
- Operational Value: Provides a defined system for functional target validation and pathway clarification in neurodegenerative contexts.
- Predictive Value: Supports mechanistic de-risking by generating disease-relevant neural cells from hematopoietic progenitors.
Screening & Assay Development
- Scientific Value: Produces standardized neural stem cells for consistent compound screening and phenotypic assessment.
- Operational Value: Ensures assay reproducibility through defined extracellular matrix and neural progenitor media conditions.
- Scalability: Supports expansion and banking of induced neural stem cells for high-throughput screening campaigns.
Translational & Preclinical Research
- Translational Continuity: Bridges hematopoietic sourcing to neural phenotypes, enabling biomarker-aligned preclinical models.
- Risk-Adjusted Advancement: Facilitates go/no-go decisions based on neural differentiation and functional readouts.
- Disease Modeling: Supports mechanistic studies in neurodegenerative disorders using induced neural stem cells.
Pipeline & Workflow Integration
The method integrates into early discovery by converting accessible hematopoietic progenitors into neural stem cells, enabling target validation and assay-ready cell production prior to lead identification.
- Discovery Biology: Supports hypothesis testing and biological de-risking through direct neural lineage conversion.
- Screening: Delivers reproducible neural stem cells for compound evaluation under standardized conditions.
- Analytics: Enables quantitative assessment of cell confluence, morphology, and medium-dependent growth.
- Translational Research: Connects peripheral blood sourcing to neural phenotypes for preclinical continuity.
- Enterprise Reuse: Establishes a scalable platform for generating neural stem cells across multiple projects and indications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neural target validation through direct, defined reprogramming.
- Operational Value: Enhances reproducibility and standardization via matrix-coated plates and conditioned media.
- Strategic Value: Improves capital efficiency by reducing reliance on pluripotent stem cell workflows.
- Portfolio Impact: Enables risk-adjusted prioritization of neural targets using biologically relevant, scalable models.
Implementation Considerations
- Requires expertise in stem cell culture, transduction, and neural differentiation techniques.
- Dependent on extracellular matrix coatings and defined neural progenitor/stem cell media formulations.
- Necessitates standardized protocols for medium changes, passaging, and confluence monitoring.
- Involves adaptation considerations when applying to different hematopoietic progenitor sources or genetic backgrounds.
- Limited by the need for genetic modification of progenitor cells to express reprogramming transcription factors.
Biopharma FAQs
An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
Related Videos
0 Views
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Related Videos
0 Views
Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes
Related Videos
0 Views
Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons
Related Videos
0 Views
Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
Related Videos
0 Views
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
Related Videos
0 Views
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
Related Videos
0 Views
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Related Videos
0 Views
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
Related Videos
0 Views
Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Related Videos
0 Views
Last updated: 22 August 2026